Background: The treatment options for patients with locally advanced pancreatic cancer (LAPC) have improved in recent years and consequently survival has increased. It is unknown, however, if elderly patients benefit from these improvements in therapy. With the ongoing aging of the patient population and an increasing incidence of pancreatic cancer, this patient group becomes more relevant. This study aims to clarify the association between increasing age, treatment and overall survival in patients with LAPC.Methods: Post-hoc analysis of a multicenter registry including consecutive patients with LAPC, who were registered in 14 centers of the Dutch Pancreatic Cancer Group (April 2015-December 2017). Patients were divided in three groups acco...
BACKGROUND: The diagnosis of pancreatic ductal adenocarcinoma (PDAC) has an enormous impact on patie...
Objectives: A significant proportion of patients with pancreatic cancer are over the age of 70 years...
Despite an aging population and underrepresentation of elderly patients in clinical trials, studies ...
Background: The treatment options for patients with locally advanced pancreatic cancer (LAPC) have i...
Background: The treatment options for patients with locally advanced pancreatic cancer (LAPC) have i...
Background: Elderly patients with pancreatic cancer are underrepresented in clinical trials, resulti...
BACKGROUND: The number of elderly patients with pancreatic cancer is growing, however clinical data ...
Background: The number of elderly patients with pancreatic cancer is growing, however clinical data ...
Background Elderly patients with pancreatic cancer are underrepresented in clinical trials, resultin...
BACKGROUND: The diagnosis of pancreatic ductal adenocarcinoma (PDAC) has an enormous impact on patie...
Objectives: A significant proportion of patients with pancreatic cancer are over the age of 70 years...
Despite an aging population and underrepresentation of elderly patients in clinical trials, studies ...
Background: The treatment options for patients with locally advanced pancreatic cancer (LAPC) have i...
Background: The treatment options for patients with locally advanced pancreatic cancer (LAPC) have i...
Background: Elderly patients with pancreatic cancer are underrepresented in clinical trials, resulti...
BACKGROUND: The number of elderly patients with pancreatic cancer is growing, however clinical data ...
Background: The number of elderly patients with pancreatic cancer is growing, however clinical data ...
Background Elderly patients with pancreatic cancer are underrepresented in clinical trials, resultin...
BACKGROUND: The diagnosis of pancreatic ductal adenocarcinoma (PDAC) has an enormous impact on patie...
Objectives: A significant proportion of patients with pancreatic cancer are over the age of 70 years...
Despite an aging population and underrepresentation of elderly patients in clinical trials, studies ...